The Centers for Medicare and Medicaid Services (CMS) announced a new five-year (CY 2020-2024) payment model to address the high list[…]
Read more
Latest Posts
Drugs, Medical Devices, and DME HCPCS Coding Changes for 2021
Having reimbursement issues? Need a new coding strategy? Don’t know where to start? Check out our video below for a[…]
Read more
Check out our FREE eBook!
We have created a free eBook just for you! Look at our short video for more details. You can also[…]
Read more
Is #Medtech prepared for 2021 Regulatory Changes?
Watch our short video to see some of the regulatory changes happening this year to create a healthcare system that[…]
Read more
#Medtech Reimbursement Changes 2021: Medicare Advantage (MA) Changes for Beneficiaries with End-Stage Renal Disease (ESRD)
What does the future hold for #Medtech? Take a look at our short video with details regarding Medicare Advantage changes[…]
Read more
How does the 2021 Physician Fee Schedule Impact #Medtech?
For more information, email us at info@girsinc.com or call us at 901-834-9119. On December 1, 2020, the Centers for Medicare[…]
Read more
Is #Medtech prepared for Payer Market Consolidation?
For more information, email us at info@girsinc.com or call us at 901-834-9119. GIRS tracks payer market mergers and other trends[…]
Read more
How will the Hospital Inpatient Prospective Payment System (IPPS) And Long-Term Acute Care Hospital (LTCH) Impact Medtech?
For reimbursement services support, email us at info@girsinc.com or call us at 901-834-9119. On September 2, 2020, the Centers for[…]
Read more
Has #Medtech Updated Payer Strategies for Changes in Medicare Advantage Plans?
End Stage Renal Disease also known as kidney failure, affects more than 500,000 Medicare beneficiaries. Under old rules, Medicare Advantage[…]
Read more
Medicare Advantage Record Growth Expected in 2021- What does this Mean for #Medtech?
Currently, approximately thirty-three percent of the population that is 65 and older in the United States (over 25 million people)[…]
Read more